Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer|Breast Neoplasms
Interventions: DRUG: Talazoparib
Sponsor: Pfizer